Inicio › Cáncer de endometrio › Virginia › Arlington
Ensayos clínicos de Cáncer de endometrio en Arlington, VA
39 estudios para Cáncer de endometrio buscan participantes en centros de Arlington y alrededores (a unos 30 millas). Abra un estudio para ver quién puede participar y cómo contactar con el equipo.
Texto oficial del estudio (inglés)
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
ReclutandoFase 2
- Inova Fairfax Hospital, Falls Church · A 4 mi de distancia
- Inova Schar Cancer Institute, Fairfax · A 11 mi de distancia
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
ReclutandoFase 1/2
- Virginia Cancer Specialists, Fairfax · A 11 mi de distancia
A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors
ReclutandoFase 1
- Inova Schar Cancer Institute, Fairfax · A 11 mi de distancia
- NEXT Virginia, Fairfax · A 11 mi de distancia
A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors
ReclutandoFase 1
- NEXT Virginia, Fairfax · A 11 mi de distancia
A Phase 1, First-in-Human (FIH), Open-Label, Dose-Escalation and Dose Expansion Study of the Peptide Drug Conjugate (PDC), TS-104, as a Monotherapy in Subjects With Select Advanced Solid Tumors
ReclutandoFase 1
- Site 04, Fairfax · A 11 mi de distancia
Study of AVZO-021 in Patients With Advanced Solid Tumors
ReclutandoFase 1/2
- Avenzo Therapeutics Recruiting Site, Fairfax · A 11 mi de distancia
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
ReclutandoFase 1/2
- NEXT Oncology Virginia, Fairfax · A 11 mi de distancia
Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors
ReclutandoFase 1
- Virginia Cancer Specialists, Fairfax · A 11 mi de distancia
A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone as Treatment in Participants With Mismatch Repair Proficient Endometrial Cancer (MK-2870-033/TroFuse-033/GOG-3119/ENGOT-en29)
ReclutandoFase 3
- Inova Schar Cancer Institute ( Site 6003), Fairfax · A 11 mi de distancia
- Virginia Cancer Specialists (VCS) ( Site 8008), Fairfax · A 11 mi de distancia
A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations
ReclutandoFase 1/2
- NEXT Oncology, Fairfax · A 11 mi de distancia
Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors
ReclutandoFase 1
- Virginia Cancer Specialists, Fairfax · A 11 mi de distancia
Phase 1 Study to Assess Safety, Tolerability, Pharmacokinetics, Immunogenicity, and Antitumor Activity of ARR-002 in Advanced or Metastatic Ovarian or Endometrial Cancer.
ReclutandoFase 1
- NEXT Oncology, Fairfax · A 11 mi de distancia
DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer
ReclutandoFase 3
- Research Site, Fairfax · A 11 mi de distancia
A Study of STRO-004 in Adults With Refractory/Recurrent Metastatic Cancer
ReclutandoFase 1
- NEXT Virginia, Fairfax · A 11 mi de distancia
A Study of Mutant Selective-Inhibitor (CGT6297), in Patients With Advanced Solid Tumors
ReclutandoFase 1
- NEXT Virginia, Fairfax · A 11 mi de distancia
A Phase 1 Study of LNCB74 in Advanced Solid Tumors
ReclutandoFase 1
- Inova Schar Cancer Institute, Falls Church · A 4 mi de distancia
Phase I/IIa Study of AZD5335 as Monotherapy and Combination Therapy in Participants With Solid Tumors
ReclutandoFase 1/2
- Research Site, Fairfax · A 11 mi de distancia
A Phase 1 Study of NRM-823 in Participants With Locally Advanced or Metastatic Refractory Solid Tumors
ReclutandoFase 1
- Normunity Investigational Site, Fairfax · A 11 mi de distancia
A Study of PHST001 in Advanced Solid Tumors
ReclutandoFase 1
- NEXT Oncology - Virginia, Fairfax · A 11 mi de distancia
Study Evaluating the Safety and Efficacy of HWK-007, a PTK7-directed Antibody Drug Conjugate in Participants With Advanced Solid Tumors
ReclutandoFase 1
- NEXT Oncology - Virginia Cancer Specialists, Fairfax · A 11 mi de distancia
A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)
ReclutandoFase 1/2
- Virginia Cancer Specialists, Fairfax · A 11 mi de distancia
Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
ReclutandoFase 1/2
- USOR Virginia Cancer Specialists, Fairfax · A 11 mi de distancia
A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors
ReclutandoFase 1/2
- Virginia Cancer Specialists, Fairfax · A 11 mi de distancia
Puxitatug Samrotecan (AZD8205) Monotherapy vs Chemotherapy in B7-H4-selected Endometrial Cancer (Bluestar-Endometrial01)
ReclutandoFase 3
- Research Site, Falls Church · A 4 mi de distancia
- Research Site, Fairfax · A 11 mi de distancia
A Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors
ReclutandoFase 1
- NEXT Virginia, Fairfax · A 11 mi de distancia
Study of RGT-490 in Patients With PIK3CA-Mutated Advanced Solid Tumors
ReclutandoFase 1
- NEXT Virginia, Fairfax · A 11 mi de distancia
Relacorilant in Combination With Different Treatment Regimens in Patients With Gynecological Cancers
ReclutandoFase 2
- 522, Fairfax · A 11 mi de distancia
First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors
ReclutandoFase 1/2
- USO-Virginia Cancer Specialists, PC, Fairfax · A 11 mi de distancia
A Phase 1 Dose-escalation Trial of KST-6051 in Participants With Advanced Solid Tumors With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Mutation
ReclutandoFase 1
- NEXT Virginia, Fairfax · A 11 mi de distancia
A Study of Emiltatug Ledadotin (Emi-Le) in Participants With Solid Tumors
ReclutandoFase 1/2
- NEXT Oncology Virginia, Fairfax · A 11 mi de distancia
Phase 1/2 Study of ETX-636 in Participants With Advanced Solid Tumors
ReclutandoFase 1/2
- NEXT, Fairfax · A 11 mi de distancia
A Study of LY4175408 in Participants With Advanced Cancer
ReclutandoFase 1
- NEXT Virginia, Fairfax · A 11 mi de distancia
A Study of IDE034 in Adult Participants With Locally Advanced/Metastatic Solid Tumors Types
ReclutandoFase 1
- NEXT Texas LLC - Virginia, Fairfax · A 11 mi de distancia
A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies
ReclutandoFase 1/2
- Virginia Cancer Specialists, Fairfax · A 11 mi de distancia
First in Human Study of TORL-1-23 in Participants With Advanced Cancer
ReclutandoFase 1
- Virginia Cancer Specialists, Fairfax · A 11 mi de distancia
A Study of DR-0202 in Patients With Locally Advanced or Metastatic, Relapsed or Refractory Carcinomas
ReclutandoFase 1
- Dren Investigational Site, Fairfax · A 11 mi de distancia
Sapanisertib and Serabelisib (PIKTOR) With Paclitaxel and a Substudy With an Insulin-Suppressing Diet in Patients With Advanced/Recurrent Endometrial Cancer
ReclutandoFase 2
- Virginia Cancer Specialists, P.C., Fairfax · A 11 mi de distancia
Phase 1 Study Evaluating the Safety and PK of ADU-1805 in Advanced Solid Tumors
ReclutandoFase 1
- Virginia Cancer Specialists, Fairfax · A 11 mi de distancia
A Study of GV20-0251 Monotherapy and GV20-0251 in Combination With Pembrolizumab in Participants With Solid Tumor Malignancies
ReclutandoFase 1/2
- Virginia Cancer Specialists, Fairfax · A 11 mi de distancia
Ensayos de Cáncer de endometrio en otras ciudades
- Houston, TX68 estudios
- New York City, NY52 estudios
- Boston, MA50 estudios
- Nashville, TN38 estudios
- Los Angeles, CA34 estudios
- St. Louis, MO29 estudios
- Philadelphia, PA28 estudios
- San Antonio, TX27 estudios
- Chicago, IL25 estudios
- Columbus, OH25 estudios
- Queens, NY25 estudios
- Oklahoma City, OK25 estudios
Otros estudios en Arlington
- Cáncer de pulmón de células no pequeñas104 estudios
- Cáncer metastásico53 estudios
- Cáncer del colon y del recto52 estudios
- Cáncer (todos los tipos)48 estudios
- Cáncer de seno46 estudios
- Cáncer de ovario46 estudios
- Cáncer de pulmón41 estudios
- Cáncer de páncreas33 estudios
- Carcinoma de células escamosas de cabeza y cuello26 estudios
- Cáncer de pulmón de células pequeñas23 estudios
- Cáncer de mama triple negativo20 estudios
- Cáncer de estómago20 estudios
De ClinicalTrials.gov, datos obtenidos el 5 oct 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.